Evidence map›Paper›PMID 36949421›Full record

ArticleBMC public health2023

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.

Xi-Ru Zhang, Zhi-Ju Li, Qi Fu, Jin-Dong Wang, Qing-Mei Huang, Wei-Qi Song, Xiao-Yu Xu, Zhi-Hao Li, Chen Mao

Open access · goldFull text read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. A Critical Review of the CRISPR-Cas Technology in the Detection of SARS-CoV-2 Variants.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xi-Ru Zhang *Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Zhi-Ju Li *Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Qi FuDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Jin-Dong WangDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Qing-Mei HuangDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Wei-Qi SongDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Xiao-Yu XuDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Zhi-Hao LiDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
Chen MaoDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China. maochen9@smu.edu.cn.ORCID 0000-0002-6537-6215
Southern Medical University · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness.

methodsA cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated.

resultsAmong 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated.

conclusionAlthough the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination.

Indexed as

COVID-19 VaccinesAdultChinaFemaleHumansLogistic ModelsMaleMiddle AgedOccupational GroupsPatient Acceptance of Health CareSARS-CoV-2COVID-19 VaccinesCoronavirus disease 2019CoverageRelated factorVaccinationWillingness

Identifiers

PMID36949421
PMCPMC10031186
OpenAlexW4360599439

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read40
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.